The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality.
Treatment with intravenous iron is clearly superior to oral iron and presents several advantages such as faster and higher increase in Hb levels and replenishment of body iron stores. For these reasons, modern formulations of IV iron have emerged as safe and effective alternatives for IDA management.
The global Intravenous Iron Drugs market was valued at US$ 1449.2 million in 2020 and is expected to reach US$ 1977.2 million by the end of 2027, growing at a CAGR of 4.1% during 2021-2027.
This report focuses on Intravenous Iron Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Intravenous Iron Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Intravenous Iron Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Ferric Gluconate
- Ferric Carboxymaltose
- Iron Sucrose
- Iron Dextran
Segment by Application
- Nephrology
- Gynecology & Obstetrics
- Gastroenterology
- Oncology
- Cardiology
- Others
Consumption by Region
- North America (United States, Canada, Mexico)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
- Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)
By Company
- Allergan
- AMAG Pharmaceuticals
- Daiichi Sankyo
- Galenica
- Pharmacosmos
- Nippon Shinyaku
- NOXXON Pharma
- Rockwell Medical
- Sanofi
- Wanbang Biopharmaceutical
Scope of the Intravenous Iron Drugs Market Report
|
Report Metric |
Details |
|
Report Name |
Intravenous Iron Drugs Market |
|
Market size in 2021 |
US$ 1449.2 Million |
|
The revenue forecast in 2027 |
US$ 1977.2 Million |
|
Growth Rate |
CAGR of 4.1% from 2021 to 2027 |
|
Market size available for years |
2020-2027 |
|
Forecast units |
Value (USD) & Volume (Units) |
|
Segments covered |
Types, End-User / Applications, Companies, and Region |
|
Report coverage |
Revenue & volume forecast, company share, competitive landscape, growth factors, and trends |
|
Geographic regions covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Index
1 Intravenous Iron Drugs Market Overview
1.1 Product Overview and Scope of Intravenous Iron Drugs
1.2 Intravenous Iron Drugs Segment by Type
1.2.1 Global Intravenous Iron Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Ferric Gluconate
1.2.3 Ferric Carboxymaltose
1.2.4 Iron Sucrose
1.2.5 Iron Dextran
1.3 Intravenous Iron Drugs Segment by Application
1.3.1 Global Intravenous Iron Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Nephrology
1.3.3 Gynecology & Obstetrics
1.3.4 Gastroenterology
1.3.5 Oncology
1.3.6 Cardiology
1.3.7 Others
1.4 Global Intravenous Iron Drugs Market Size Estimates and Forecasts
1.4.1 Global Intravenous Iron Drugs Revenue 2016-2027
1.4.2 Global Intravenous Iron Drugs Sales 2016-2027
1.4.3 Intravenous Iron Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Intravenous Iron Drugs Market Competition by Manufacturers
2.1 Global Intravenous Iron Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Intravenous Iron Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Intravenous Iron Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Intravenous Iron Drugs Manufacturing Sites, Area Served, Product Type
2.5 Intravenous Iron Drugs Market Competitive Situation and Trends
2.5.1 Intravenous Iron Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intravenous Iron Drugs Players Market Share by Revenue
2.5.3 Global Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Iron Drugs Retrospective Market Scenario by Region
3.1 Global Intravenous Iron Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Intravenous Iron Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Intravenous Iron Drugs Market Facts & Figures by Country
3.3.1 North America Intravenous Iron Drugs Sales by Country
3.3.2 North America Intravenous Iron Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Intravenous Iron Drugs Market Facts & Figures by Country
3.4.1 Europe Intravenous Iron Drugs Sales by Country
3.4.2 Europe Intravenous Iron Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravenous Iron Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Intravenous Iron Drugs Sales by Region
3.5.2 Asia Pacific Intravenous Iron Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Intravenous Iron Drugs Market Facts & Figures by Country
3.6.1 Latin America Intravenous Iron Drugs Sales by Country
3.6.2 Latin America Intravenous Iron Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Intravenous Iron Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravenous Iron Drugs Sales by Country
3.7.2 Middle East and Africa Intravenous Iron Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Intravenous Iron Drugs Historic Market Analysis by Type
4.1 Global Intravenous Iron Drugs Sales Market Share by Type (2016-2021)
4.2 Global Intravenous Iron Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Intravenous Iron Drugs Price by Type (2016-2021)
5 Global Intravenous Iron Drugs Historic Market Analysis by Application
5.1 Global Intravenous Iron Drugs Sales Market Share by Application (2016-2021)
5.2 Global Intravenous Iron Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Intravenous Iron Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Allergan Intravenous Iron Drugs Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 AMAG Pharmaceuticals
6.2.1 AMAG Pharmaceuticals Corporation Information
6.2.2 AMAG Pharmaceuticals Description and Business Overview
6.2.3 AMAG Pharmaceuticals Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 AMAG Pharmaceuticals Intravenous Iron Drugs Product Portfolio
6.2.5 AMAG Pharmaceuticals Recent Developments/Updates
6.3 Daiichi Sankyo
6.3.1 Daiichi Sankyo Corporation Information
6.3.2 Daiichi Sankyo Description and Business Overview
6.3.3 Daiichi Sankyo Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Daiichi Sankyo Intravenous Iron Drugs Product Portfolio
6.3.5 Daiichi Sankyo Recent Developments/Updates
6.4 Galenica
6.4.1 Galenica Corporation Information
6.4.2 Galenica Description and Business Overview
6.4.3 Galenica Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Galenica Intravenous Iron Drugs Product Portfolio
6.4.5 Galenica Recent Developments/Updates
6.5 Pharmacosmos
6.5.1 Pharmacosmos Corporation Information
6.5.2 Pharmacosmos Description and Business Overview
6.5.3 Pharmacosmos Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pharmacosmos Intravenous Iron Drugs Product Portfolio
6.5.5 Pharmacosmos Recent Developments/Updates
6.6 Nippon Shinyaku
6.6.1 Nippon Shinyaku Corporation Information
6.6.2 Nippon Shinyaku Description and Business Overview
6.6.3 Nippon Shinyaku Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Nippon Shinyaku Intravenous Iron Drugs Product Portfolio
6.6.5 Nippon Shinyaku Recent Developments/Updates
6.7 NOXXON Pharma
6.6.1 NOXXON Pharma Corporation Information
6.6.2 NOXXON Pharma Description and Business Overview
6.6.3 NOXXON Pharma Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 NOXXON Pharma Intravenous Iron Drugs Product Portfolio
6.7.5 NOXXON Pharma Recent Developments/Updates
6.8 Rockwell Medical
6.8.1 Rockwell Medical Corporation Information
6.8.2 Rockwell Medical Description and Business Overview
6.8.3 Rockwell Medical Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Rockwell Medical Intravenous Iron Drugs Product Portfolio
6.8.5 Rockwell Medical Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Sanofi Intravenous Iron Drugs Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Wanbang Biopharmaceutical
6.10.1 Wanbang Biopharmaceutical Corporation Information
6.10.2 Wanbang Biopharmaceutical Description and Business Overview
6.10.3 Wanbang Biopharmaceutical Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Wanbang Biopharmaceutical Intravenous Iron Drugs Product Portfolio
6.10.5 Wanbang Biopharmaceutical Recent Developments/Updates
7 Intravenous Iron Drugs Manufacturing Cost Analysis
7.1 Intravenous Iron Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravenous Iron Drugs
7.4 Intravenous Iron Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intravenous Iron Drugs Distributors List
8.3 Intravenous Iron Drugs Customers
9 Intravenous Iron Drugs Market Dynamics
9.1 Intravenous Iron Drugs Industry Trends
9.2 Intravenous Iron Drugs Growth Drivers
9.3 Intravenous Iron Drugs Market Challenges
9.4 Intravenous Iron Drugs Market Restraints
10 Global Market Forecast
10.1 Intravenous Iron Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intravenous Iron Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Intravenous Iron Drugs by Type (2022-2027)
10.2 Intravenous Iron Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intravenous Iron Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Intravenous Iron Drugs by Application (2022-2027)
10.3 Intravenous Iron Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravenous Iron Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Intravenous Iron Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Intravenous Iron Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Intravenous Iron Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Intravenous Iron Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Intravenous Iron Drugs Covered in This Study
Table 5. Global Intravenous Iron Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Intravenous Iron Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Intravenous Iron Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Intravenous Iron Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Intravenous Iron Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Intravenous Iron Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Intravenous Iron Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intravenous Iron Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Iron Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Intravenous Iron Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Intravenous Iron Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Intravenous Iron Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Intravenous Iron Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Intravenous Iron Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Intravenous Iron Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Intravenous Iron Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Intravenous Iron Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Intravenous Iron Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Intravenous Iron Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Intravenous Iron Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Intravenous Iron Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Intravenous Iron Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Intravenous Iron Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Intravenous Iron Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Intravenous Iron Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Intravenous Iron Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Intravenous Iron Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Intravenous Iron Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Intravenous Iron Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Intravenous Iron Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Intravenous Iron Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Intravenous Iron Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Intravenous Iron Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Intravenous Iron Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Intravenous Iron Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Intravenous Iron Drugs Revenue Share by Type (2016-2021)
Table 42. Global Intravenous Iron Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Intravenous Iron Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Intravenous Iron Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Intravenous Iron Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Intravenous Iron Drugs Revenue Share by Application (2016-2021)
Table 47. Global Intravenous Iron Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. Allergan Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Allergan Intravenous Iron Drugs Product
Table 52. Allergan Recent Developments/Updates
Table 53. AMAG Pharmaceuticals Corporation Information
Table 54. AMAG Pharmaceuticals Description and Business Overview
Table 55. AMAG Pharmaceuticals Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. AMAG Pharmaceuticals Intravenous Iron Drugs Product
Table 57. AMAG Pharmaceuticals Recent Developments/Updates
Table 58. Daiichi Sankyo Corporation Information
Table 59. Daiichi Sankyo Description and Business Overview
Table 60. Daiichi Sankyo Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Daiichi Sankyo Intravenous Iron Drugs Product
Table 62. Daiichi Sankyo Recent Developments/Updates
Table 63. Galenica Corporation Information
Table 64. Galenica Description and Business Overview
Table 65. Galenica Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Galenica Intravenous Iron Drugs Product
Table 67. Galenica Recent Developments/Updates
Table 68. Pharmacosmos Corporation Information
Table 69. Pharmacosmos Description and Business Overview
Table 70. Pharmacosmos Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Pharmacosmos Intravenous Iron Drugs Product
Table 72. Pharmacosmos Recent Developments/Updates
Table 73. Nippon Shinyaku Corporation Information
Table 74. Nippon Shinyaku Description and Business Overview
Table 75. Nippon Shinyaku Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Nippon Shinyaku Intravenous Iron Drugs Product
Table 77. Nippon Shinyaku Recent Developments/Updates
Table 78. NOXXON Pharma Corporation Information
Table 79. NOXXON Pharma Description and Business Overview
Table 80. NOXXON Pharma Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. NOXXON Pharma Intravenous Iron Drugs Product
Table 82. NOXXON Pharma Recent Developments/Updates
Table 83. Rockwell Medical Corporation Information
Table 84. Rockwell Medical Description and Business Overview
Table 85. Rockwell Medical Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Rockwell Medical Intravenous Iron Drugs Product
Table 87. Rockwell Medical Recent Developments/Updates
Table 88. Sanofi Corporation Information
Table 89. Sanofi Description and Business Overview
Table 90. Sanofi Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Sanofi Intravenous Iron Drugs Product
Table 92. Sanofi Recent Developments/Updates
Table 93. Wanbang Biopharmaceutical Corporation Information
Table 94. Wanbang Biopharmaceutical Description and Business Overview
Table 95. Wanbang Biopharmaceutical Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Wanbang Biopharmaceutical Intravenous Iron Drugs Product
Table 97. Wanbang Biopharmaceutical Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Intravenous Iron Drugs Distributors List
Table 101. Intravenous Iron Drugs Customers List
Table 102. Intravenous Iron Drugs Market Trends
Table 103. Intravenous Iron Drugs Growth Drivers
Table 104. Intravenous Iron Drugs Market Challenges
Table 105. Intravenous Iron Drugs Market Restraints
Table 106. Global Intravenous Iron Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 107. Global Intravenous Iron Drugs Sales Market Share Forecast by Type (2022-2027)
Table 108. Global Intravenous Iron Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 109. Global Intravenous Iron Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 110. Global Intravenous Iron Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 111. Global Intravenous Iron Drugs Sales Market Share Forecast by Application (2022-2027)
Table 112. Global Intravenous Iron Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 113. Global Intravenous Iron Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 114. Global Intravenous Iron Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 115. Global Intravenous Iron Drugs Sales Market Share Forecast by Region (2022-2027)
Table 116. Global Intravenous Iron Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 117. Global Intravenous Iron Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravenous Iron Drugs
Figure 2. Global Intravenous Iron Drugs Market Share by Type in 2020 & 2027
Figure 3. Ferric Gluconate Product Picture
Figure 4. Ferric Carboxymaltose Product Picture
Figure 5. Iron Sucrose Product Picture
Figure 6. Iron Dextran Product Picture
Figure 7. Global Intravenous Iron Drugs Market Share by Application in 2020 & 2027
Figure 8. Nephrology
Figure 9. Gynecology & Obstetrics
Figure 10. Gastroenterology
Figure 11. Oncology
Figure 12. Cardiology
Figure 13. Others
Figure 14. Global Intravenous Iron Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Intravenous Iron Drugs Market Size 2016-2027 (US$ Million)
Figure 16. Global Intravenous Iron Drugs Sales 2016-2027 (K Units)
Figure 17. Global Intravenous Iron Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Intravenous Iron Drugs Sales Share by Manufacturers in 2020
Figure 19. Global Intravenous Iron Drugs Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Intravenous Iron Drugs Players: Market Share by Revenue in 2020
Figure 21. Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Intravenous Iron Drugs Sales Market Share by Region (2016-2021)
Figure 23. Global Intravenous Iron Drugs Sales Market Share by Region in 2020
Figure 24. Global Intravenous Iron Drugs Revenue Market Share by Region (2016-2021)
Figure 25. Global Intravenous Iron Drugs Revenue Market Share by Region in 2020
Figure 26. U.S. Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Intravenous Iron Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Intravenous Iron Drugs by Type (2016-2021)
Figure 51. Sales Market Share of Intravenous Iron Drugs by Application (2016-2021)
Figure 52. Sales Market Share of Intravenous Iron Drugs by Application in 2020
Figure 53. Revenue Share of Intravenous Iron Drugs by Application (2016-2021)
Figure 54. Revenue Share of Intravenous Iron Drugs by Application in 2020
Figure 55. Manufacturing Cost Structure of Intravenous Iron Drugs
Figure 56. Manufacturing Process Analysis of Intravenous Iron Drugs
Figure 57. Intravenous Iron Drugs Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
